Tag: breast cancer patients
Eli Lilly introduces Ramiven® (abemaciclib) in India, for certain high-risk early...
Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 - node positive high risk early breast cancer.